6.
Koester K, Erguera X, Udoh I, Kang Dufour M, Burack J, Myers J
. Exploring the Shift From HIV Pre-exposure Prophylaxis Awareness to Uptake Among Young Gay and Bisexual Men. Front Public Health. 2021; 9:677716.
PMC: 8688695.
DOI: 10.3389/fpubh.2021.677716.
View
7.
S Patel A, Goparaju L, Sales J, Mehta C, Blackstock O, Seidman D
. Brief Report: PrEP Eligibility Among At-Risk Women in the Southern United States: Associated Factors, Awareness, and Acceptability. J Acquir Immune Defic Syndr. 2019; 80(5):527-532.
PMC: 6519058.
DOI: 10.1097/QAI.0000000000001950.
View
8.
Nunn A, Brinkley-Rubinstein L, Oldenburg C, Mayer K, Mimiaga M, Patel R
. Defining the HIV pre-exposure prophylaxis care continuum. AIDS. 2017; 31(5):731-734.
PMC: 5333727.
DOI: 10.1097/QAD.0000000000001385.
View
9.
Christopoulos K, Olender S, Lopez A, Lekas H, Jaiswal J, Mellman W
. Retained in HIV Care But Not on Antiretroviral Treatment: A Qualitative Patient-Provider Dyadic Study. PLoS Med. 2015; 12(8):e1001863.
PMC: 4532493.
DOI: 10.1371/journal.pmed.1001863.
View
10.
Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock P, Leethochawalit M
. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013; 381(9883):2083-90.
DOI: 10.1016/S0140-6736(13)61127-7.
View
11.
Roth A, Aumaier B, Felsher M, Welles S, Martinez-Donate A, Chavis M
. An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users. Sex Transm Dis. 2018; 45(4):217-221.
DOI: 10.1097/OLQ.0000000000000728.
View
12.
Barendregt C, van der Poel A, van de Mheen D
. Tracing selection effects in three non-probability samples. Eur Addict Res. 2005; 11(3):124-31.
DOI: 10.1159/000085547.
View
13.
Stein M, Thurmond P, Bailey G
. Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS Behav. 2014; 18(9):1694-700.
PMC: 4127116.
DOI: 10.1007/s10461-014-0778-z.
View
14.
Hedegaard H, Minino A, Warner M
. Drug Overdose Deaths in the United States, 1999-2018. NCHS Data Brief. 2020; (356):1-8.
View
15.
Tuchman E
. Women and addiction: the importance of gender issues in substance abuse research. J Addict Dis. 2010; 29(2):127-38.
DOI: 10.1080/10550881003684582.
View
16.
Evans M, Labuda S, Hogan V, Agnew-Brune C, Armstrong J, Periasamy Karuppiah A
. Notes from the Field: HIV Infection Investigation in a Rural Area - West Virginia, 2017. MMWR Morb Mortal Wkly Rep. 2018; 67(8):257-258.
PMC: 5861700.
DOI: 10.15585/mmwr.mm6708a6.
View
17.
Hamilton J
. Rigor in Qualitative Methods: An Evaluation of Strategies Among Underrepresented Rural Communities. Qual Health Res. 2019; 30(2):196-204.
DOI: 10.1177/1049732319860267.
View
18.
Coyne C, Demian-Popescu C, Friend D
. Social and cultural factors influencing health in southern West Virginia: a qualitative study. Prev Chronic Dis. 2006; 3(4):A124.
PMC: 1779288.
View
19.
Ondocsin J, Mars S, Howe M, Ciccarone D
. Hostility, compassion and role reversal in West Virginia's long opioid overdose emergency. Harm Reduct J. 2020; 17(1):74.
PMC: 7549084.
DOI: 10.1186/s12954-020-00416-w.
View
20.
Mistler C, Copenhaver M, Shrestha R
. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review. AIDS Behav. 2020; 25(5):1490-1506.
PMC: 7858689.
DOI: 10.1007/s10461-020-02988-x.
View